Lannett Co Inc (LCI) Price Targets From Analysts
Use the tables below to see what analysts covering Lannett Co Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 4 | $7.5 | $5 | $6.38 | $6.09 | 4.76% |
The Trend in the Analyst Price Target
Over the past 7 days, LCI's average price target has gone down $0.
LCI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 5 | 0 | 0 | 5 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The average analyst price target of LCI is greater than 12.61% of all US stocks.
- LCI has a greater upside potential (average analyst target price relative to current price) than 13.97% of Pharmaceutical Products stocks.
- Lannett Co Inc's number of analysts covering the stock is greater than 18.63% of stocks in the mid market cap category.
- LCI has a less variance in analysts' estimates than 37.14% of all US stocks.
- LCI has a higher NA than just about none of of all US stocks.
Stocks similar to Lannett Co Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are APRE, PAHC and PRLD.
What is the outlook for LCI? Use POWR Ratings for clearer insight into price direction.